We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KAMN
2026
DELISTED
Kaman Corp
KAMN
| $615K | ﹤0.01% |
17,165
-139
| -0.8% | -$5.44K |
|
|
EDE
2027
DELISTED
Empire District Electric
EDE
| $614K | ﹤0.01% |
27,866
-1,125
| -4% | -$25.1K |
|
2028
Associated Banc-Corp
ASB
$5.8B
| $612K | ﹤0.01% |
34,075
+12,048
| +55% | +$230K |
|
|
ARI
2029
Apollo Commercial Real Estate
ARI
$864M
| $611K | ﹤0.01% |
38,908
+125
| +0.3% | +$2.08K |
|
2030
Encore Capital Group
ECPG
$2.01B
| $611K | ﹤0.01% |
16,527
-509
| -3% | -$20.8K |
|
2031
PUT
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
| $611K | ﹤0.01% |
+4,900
| New | +$605K |
|
|
SPTN
2032
DELISTED
SpartanNash
SPTN
| $611K | ﹤0.01% |
23,623
-887
| -4% | -$26.8K |
|
2033
AMERISAFE
AMSF
$562M
| $610K | ﹤0.01% |
12,275
-524
| -4% | -$25.3K |
|
|
CSR
2034
Centerspace
CSR
$952M
| $610K | ﹤0.01% |
7,879
+64
| +0.8% | +$4.58K |
|
2035
Otter Tail
OTTR
$3.81B
| $610K | ﹤0.01% |
23,416
-762
| -3% | -$20.1K |
|
|
BOBE
2036
DELISTED
Bob Evans Farms, Inc.
BOBE
| $609K | ﹤0.01% |
14,049
-1,546
| -10% | -$73.1K |
|
|
FNFV
2037
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $608K | ﹤0.01% |
51,880
-1,958
| -4% | -$28.4K |
|
|
PMT
2038
PennyMac Mortgage Investment
PMT
$845M
| $607K | ﹤0.01% |
39,267
| – | – |
|
|
CALD
2039
DELISTED
Callidus Software, Inc.
CALD
| $607K | ﹤0.01% |
35,701
-158
| -0.4% | -$2.53K |
|
|
FSP
2040
Franklin Street Properties
FSP
$49.8M
| $606K | ﹤0.01% |
56,378
-2,525
| -4% | -$28.2K |
|
|
ECOL
2041
DELISTED
US Ecology, Inc.
ECOL
| $606K | ﹤0.01% |
13,881
-216
| -2% | -$10.3K |
|
2042
Green Plains
GPRE
$1.15B
| $603K | ﹤0.01% |
30,969
+469
| +2% | +$10.3K |
|
2043
MannKind Corp
MNKD
$1.19B
| $603K | ﹤0.01% |
37,542
-36,530
| -49% | -$776K |
|
2044
Stewart Information Services
STC
$2.14B
| $603K | ﹤0.01% |
14,746
-122
| -0.8% | -$4.84K |
|
|
KKD
2045
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $603K | ﹤0.01% |
41,237
-1,452
| -3% | -$25.5K |
|
2046
Vale
VALE
$62.3B
| $602K | ﹤0.01% |
143,300
-100,000
| -41% | -$511K |
|
|
CIM
2047
Chimera Investment
CIM
$1.06B
| $601K | ﹤0.01% |
14,988
+5,006
| +50% | +$211K |
|
|
CCMP
2048
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $601K | ﹤0.01% |
15,516
-294
| -2% | -$12.8K |
|
|
SHLM
2049
DELISTED
Schulman (A.) Inc
SHLM
| $601K | ﹤0.01% |
18,498
-475
| -3% | -$16.8K |
|
|
DENN
2050
DELISTED
Denny's
DENN
| $600K | ﹤0.01% |
54,356
-2,487
| -4% | -$29K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.